TipRanks
Go Ultimate55% OFF

British American Tobacco (BMT) AI Stock Analysis

CH:BMT

British American Tobacco

(BX Swiss:BMT)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
New Categories GrowthRapid growth in New Categories, especially Modern Oral, demonstrates successful diversification beyond combustibles and improving scale economics. Rising contribution and gross profit indicate that investment is translating into a more meaningful, potentially durable earnings stream.
Negative Factors
Meaningful LeverageElevated debt reduces flexibility when operating conditions weaken and commits a significant portion of cash generation to financing obligations. Although management targets leverage of 2.0–2.5x, the existing capital structure remains an enduring constraint on investment and resilience.

British American Tobacco (BMT) vs. iShares MSCI Switzerland ETF (EWL)

-5%0%5%10%15%20%CH:BMT0.00%EWL+18.85%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
CHF 98.70B
Dividend Yield
6.12%
Average Volume (3M)
―
Price to Earnings (P/E)
15.7
Beta (1Y)
―
Revenue Growth
-4.40%
EPS Growth
100.93%
Country
Switzerland
Employees
47,797
Sector
Consumer Defensive
Sector Strength
62
Industry
Tobacco

British American Tobacco Business Overview & Revenue Model

Company Description

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the United States, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa. The company offers vapour products; heated...

British American Tobacco Earnings Call Summary

Earnings Call Date:Jul 29, 2026(Q2-2026)|% Change Since:0.00%|Next Earnings Date:Feb 10, 2027
Earnings Call SentimentPositive

The call presented clear positive momentum across New Categories (notably Modern Oral) and a strong U.S. multi-category performance, with solid margin expansion, EPS growth (adjusted EPS +7.9%), and progress on cost transformation and cash returns. Significant regional weaknesses (notably APMEA), declines in Heated Products and Vapour in some markets, regulatory and illicit challenges, and sizeable one-off charges temper the outlook. On balance, achievements (accelerating New Category profitability, upgraded EPS guidance, margin and cash strength, Fit2Win savings visibility) outweigh the regional and category headwinds, supporting a constructive outlook while acknowledging near-term moderation and investment-driven costs.

Positive Updates

Group Financial Performance
Group revenue increased 2.9% (constant currency); adjusted gross profit rose 3.8%; adjusted profit from operations grew 3.5%; adjusted diluted EPS up 7.9%. Group operating margin expanded 30 basis points to 43.7% (10 bps at current rates).

Negative Updates

APMEA Underperformance
APMEA revenue declined 6.3%, driven primarily by combustibles; Heated Product revenue down 13% and Vapour revenue down 28% in the region; adjusted profit in APMEA declined 16.5% due to combustible headwinds, illicit trade and inventory timing.

Company Guidance

Guidance summary: management expects adjusted profit from operations to accelerate in H2 (profit second‑half weighted) driven by improvements in AME and APMEA and the phasing benefit of Fit2Win, with New Category revenue growth targeted at mid‑teens in H2 led by Velo and Vuse; full‑year revenue and operating profit are expected at the lower end of the company’s algorithm/range, absorbing around a 1% transactional FX headwind, and full‑year EPS growth is now guided toward the middle of the 5–8% range. Financial assumptions include net finance cost of ~GBP 1.65bn and an underlying tax rate of 24–25%; Fit2Win savings are expected to reach GBP 700m annualized by 2028 (GBP 500m by 2027) with total one‑off costs of ~GBP 950m (GBP 840m adjusting) mainly in 2026–27. Capital allocation and cash priorities remain intact: targeting 2–2.5x leverage by year‑end, a GBP 1.3bn share buyback in 2026 alongside a progressive dividend, and a commitment to deliver more than GBP 50bn of free cash flow by 2030.

British American Tobacco Risk Analysis

British American Tobacco disclosed 1 risk factors in its most recent earnings report. British American Tobacco reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

1 New Risk
1.2.3Supplemental Indenture No. 1, dated as of 28 September 2018, among British American Tobacco p.l.c. and certain of its subsidiaries as guarantors, and Wilmington Trust, National Association, as Trustee.4Q4, 2025

British American Tobacco Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

CH:BMT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
GB:IMBGB:IMB53NeutralGBP 21.98B13.7939.24%5.57%4.73%-28.94%

* Consumer Defensive Sector Average

Performance Comparison

-10%0%10%CH:BMTGB:IMBDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
CH:BMT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CH:BMTBritish American Tobacco (UK)39.000.000.00%
GB:IMBImperial Brands (UK)2938.0046.351.60%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.